These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 9070653)

  • 1. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
    Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
    Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E1A physically interacts with RUNX3 and inhibits its transactivation activity.
    Cha EJ; Oh BC; Wee HJ; Chi XZ; Goh YM; Lee KS; Ito Y; Bae SC
    J Cell Biochem; 2008 Sep; 105(1):236-44. PubMed ID: 18570183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
    Yang XJ; Ogryzko VV; Nishikawa J; Howard BH; Nakatani Y
    Nature; 1996 Jul; 382(6589):319-24. PubMed ID: 8684459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
    Sang N; Avantaggiati ML; Giordano A
    J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
    Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
    Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of the human glycoprotein hormone common alpha subunit gene by cAMP-response-element-binding protein (CREB)-binding protein (CBP)/p300 and p53.
    Zhang X; Grand RJ; McCabe CJ; Franklyn JA; Gallimore PH; Turnell AS
    Biochem J; 2002 Nov; 368(Pt 1):191-201. PubMed ID: 12164786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation.
    Kawasaki H; Eckner R; Yao TP; Taira K; Chiu R; Livingston DM; Yokoyama KK
    Nature; 1998 May; 393(6682):284-9. PubMed ID: 9607768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells.
    Zhang X; Xu LS; Wang ZQ; Wang KS; Li N; Cheng ZH; Huang SZ; Wei DZ; Han ZG
    FEBS Lett; 2004 Jul; 570(1-3):7-12. PubMed ID: 15251430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
    Das S; El-Deiry WS; Somasundaram K
    J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.
    Savelyeva I; Dobbelstein M
    Oncogene; 2011 Feb; 30(7):865-75. PubMed ID: 20935676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
    Liu SL; Rand A; Kelm RJ; Getz MJ
    Oncogene; 2000 Jul; 19(30):3352-62. PubMed ID: 10918592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.
    Pfitzner E; Jähne R; Wissler M; Stoecklin E; Groner B
    Mol Endocrinol; 1998 Oct; 12(10):1582-93. PubMed ID: 9773981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
    Hansen RS; Braithwaite AW
    Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.
    Scolnick DM; Chehab NH; Stavridi ES; Lien MC; Caruso L; Moran E; Berger SL; Halazonetis TD
    Cancer Res; 1997 Sep; 57(17):3693-6. PubMed ID: 9288775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B.
    Datto MB; Hu PP; Kowalik TF; Yingling J; Wang XF
    Mol Cell Biol; 1997 Apr; 17(4):2030-7. PubMed ID: 9121451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.